Genmab — April 2021
-
Den sved...
-
Jeg tror på at Genmab er i en uptrend fremadrettet ud fra hvad alle med indsigt i casen her på sitet skriver.
-
Netop Bulder ..Peter Verdult er ikke hvem som helst. Om vi kan lide det eller ej..US styrer kursen.
-
Nå..der er en ny spændende dag i morgen. Good luck to all:-)
-
God morgen.
-
Teknisk: US Health care i gennembrud på vejmod nye højder https://www.proinvestor.com/investornyt/674096/teknisk-us-health-care-i-gennembrud-pa-vejmod-nye-hojder
-
Fredagens danske avisuddrag med
Chr.Hansen, Mærsk og Nemlig: https://www.proinvestor.com/investornyt/674089/fredagens-danske-avisuddrag-med-chrhansen-maersk-og-nemlig -
-
Kesimpta
(ofatumumab) data at AAN showed reduction in disability progression independent of relapse activity in newly diagnosed patients with RMS https://www.novartis.com/news/media-releases/kesimpta-ofatumumab-data-aan-showed-reduction-disability-progression-independent-relapse-activity-newly-diagnosed-patients-rms -
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma
The MANHATTAN Nonrandomized Clinical Trial https://jamanetwork.com/journals/jamaoncology/article-abstract/2778195 -
not a fan of Zacks, but anyway; The Zacks Consensus Estimate for Imbruvica, Darzalex and Stelara is pegged at $1.2 billion, $1.22 billion and $2.18 billion, respectively. https://www.nasdaq.com/articles/will-jj-jnj-kickstart-pharma-q1-earnings-with-a-beat-2021-04-15
-
The Lancet - Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00056-5/fulltext
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind